88IV - PR Newswire Asia's news - Health Care/Hospital


111, Inc. Announces Establishment of the Special Committee SHANGHAI , Sept. 28, 2026 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special ... 2026-09-28T Health Care/Hospital Medical/Pharmaceuticals Retail
SOLA Biosciences Japan Receives AMED Grant to Advance SOL-257, Innovative Gene Therapy Aiming to Restore TDP-43 Function for ALS Patients TOKYO and BOSTON , Sept. 28, 2026 /PRNewswire/ -- SOLA Biosciences Japan GK ("SOLA Japan"), the wholly owned Japanese subsidiary of Boston-based SOLA Biosciences Inc. (together, "SOLA"), ... 2026-09-28T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer HONG KONG , Sept. 28, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that the first patient has been enrolled in COMPASSION-37 (AK104-311), a ... 2026-09-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Metaverse Lab-XR: Virtual Lab Builds Diagnostic and Teamwork Skills for Medical Technology Students A Chula Medical Technology lecturer has developed Metaverse Lab-XR , an innovative virtual laboratory that allows students to practice lab procedures and develop the soft skills needed ... 2026-09-28T Computer/Electronics Education Health Care/Hospital Higher Education
Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC SAN FRANCISCO and SUZHOU, China , Sept. 28, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, ... 2026-09-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
2026 IMS \| IASO Bio Presented FUCASO China Real-World Data - In a large China real-world study of 281 heavily pretreated, predominantly high-risk patients with relapsed/refractory plasma cell neoplasms, FUCASO achieved a 95.9% objective response rate, a 77.2% ... 2026-09-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
2026 IMS \| IASO Bio Presented First-in-Human Data of BCMA-Targeted In Vivo CAR-T Cell Therapy IASO206 — Late-breaking oral presentation of first-in-human data (LBA-11) showed that a single intravenous infusion of IASO206 generated functional BCMA CAR-T cells in vivo without lymphodepleting chemotherapy. ... 2026-09-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Second NRF2 Degrader Enters Clinical Development: Nutshell Therapeutics' NTS231 Received FDA IND Clearance SHANGHAI , Sept. 25, 2026 /PRNewswire/ -- Nutshell Therapeutics (Shanghai) Co., Ltd. ("Nutshell Therapeutics"), an innovative biotech company focused on AI-driven allosteric drug discovery, ... 2026-09-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lundbeck to establish global innovation hub in Greater Boston and relocate US headquarters The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent and partnerships. The move is part of Lundbeck's ... 2026-09-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Greenfield Dental Market Insights: Rising Dental Costs Push Thousands of Western Patients to Vietnam HANOI, Vietnam , Sept. 25, 2026 /PRNewswire/ -- Greenfield Dental has recorded a significant surge in international patient volume with over 300% growth since 2025, reflecting Vietnam's emergence as ... 2026-09-25T Health Care/Hospital Medical Equipment

PR Newswire Asia's news > Health Care/Hospital